Trial intelligence / Profile preview

AIUNI: Integral Assessment in Unipolar Depression

NCT02268487Phase 4Unknown

Sponsor
Universidade de São Paulo
Start
Jan 2014
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sertraline in major depressive disorder (MDD), sponsored by Universidade de São Paulo. Status: unknown.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02268487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02268487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call